Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

BACKGROUND: The Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial is a global adaptive platform trial of hospitalized patients with COVID-19. We describe implementation at the first US site, the UPMC health system, and offer recommendations for implementation at o...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841377/
https://www.ncbi.nlm.nih.gov/pubmed/33509275
http://dx.doi.org/10.1186/s13063-020-04997-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841377/
https://www.ncbi.nlm.nih.gov/pubmed/33509275
http://dx.doi.org/10.1186/s13063-020-04997-6

Ejemplares similares